Xilio Therapeutics annual return on assets (roa)
2021
2022
2023
2024
2025
Xilio Therapeutics Return on Assets (ROA) Growth & History (XLO)
Xilio Therapeutics's return on assets (roa) was −31.04% for fiscal 2025.
View full Xilio Therapeutics company overviewXilio Therapeutics annual return on assets (roa) history
| Fiscal year | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −31.04% | +57.21 pp |
| 2024 | 2024-12-31 | −88.24% | −11.87 pp |
| 2023 | 2023-12-31 | −76.37% | −26.98 pp |
| 2022 | 2022-12-31 | −49.39% | +10.20 pp |
| 2021 | 2021-12-31 | −59.60% | — |
Xilio Therapeutics quarterly return on assets (roa)
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.16% | +35.11 pp |
| Q1 2026 | 2026-03-31 | −23.43% | +34.86 pp |
| Q4 2025 | 2025-12-31 | −31.04% | +57.21 pp |
| Q3 2025 | 2025-09-30 | −56.14% | +26.22 pp |
| Q2 2025 | 2025-06-30 | −50.27% | +21.65 pp |
| Q1 2025 | 2025-03-31 | −58.29% | +14.82 pp |
| Q4 2024 | 2024-12-31 | −88.24% | −11.87 pp |
| Q3 2024 | 2024-09-30 | −82.36% | −13.32 pp |
| Q2 2024 | 2024-06-30 | −71.92% | −9.62 pp |
| Q1 2024 | 2024-03-31 | −73.11% | −14.96 pp |
| Q4 2023 | 2023-12-31 | −76.37% | −26.98 pp |
| Q3 2023 | 2023-09-30 | −69.04% | −7.59 pp |
| Q2 2023 | 2023-06-30 | −62.30% | +14.10 pp |
| Q1 2023 | 2023-03-31 | −58.15% | — |
| Q4 2022 | 2022-12-31 | −49.39% | — |
| Q3 2022 | 2022-09-30 | −61.45% | — |
| Q2 2022 | 2022-06-30 | −76.40% | — |
Xilio Therapeutics return on assets (roa) trends
Between the periods ended 2021-12-31 and 2025-12-31, Xilio Therapeutics's return on assets (roa) increased from −59.60% to −31.04%, a change of +28.56 percentage points. The latest reported quarter, Q2 2026, shows −15.16%.
About the metric
What return on assets means
Return on assets measures profit relative to the assets used to generate it. It can help compare operating efficiency over time, although normal ROA differs substantially between asset-light and asset-intensive industries.
Calculation and source
How return on assets is calculated
TickerStat calculates annual ROA as reported net income divided by average total assets. Quarterly observations use trailing-12-month net income and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xilio Therapeutics source filings ↗